Progesterone receptor expression contributes to gemcitabine resistance at higher ECM stiffness in breast cancer cell lines. (2022)
Attributed to:
SHeffield IMAging (SHIMA)
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1371/journal.pone.0268300
PubMed Identifier: 35617163
Publication URI: http://europepmc.org/abstract/MED/35617163
Type: Journal Article/Review
Volume: 17
Parent Publication: PloS one
Issue: 5
ISSN: 1932-6203